molecules-logo

Journal Browser

Journal Browser

Heterocyclic Chemistry in Drug Discovery

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 403

Special Issue Editor


E-Mail
Guest Editor
Department of Chemistry, Faculty of Education, Gifu University, Yanagido 1-1, Gifu 501-1193, Japan

Special Issue Information

Dear Colleagues,

New advances in synthetic methodologies that allow access to a wide variety of functionalized heterocycles are of critical importance to any scientist involved in medicinal and process chemistry aspects of drug discovery research and development. Furthermore, the recent progress of both transition metal catalysts and organocatalysts could enable easy access to available, scalable, and eco-friendly methodologies.

The first cases in the recent pandemic caused by SARS-CoV-2 were reported in Wuhan, China, and this virus was subsequently reported in 218 countries and territories. As of 2 November 2020, the World Health Organization reported 46,403,652 confirmed cases and a death toll of 1,198,569. Despite the efforts by researchers in the pharmaceutical industry and research centers of universities, no suitable medications are currently available against SARS-CoV-2. The emergence of epidemics due to two coronaviruses, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MARS), which are associated with severe mortality rates, prompted the development of a collection of drug candidates that may act against SARS-CoV-2 and are characterized by a range of heterocyclic nuclei: isatin and indoles; pyridine, quinolines, and isoquinolines; purine and pyrimidines; thiazoles; pyrazoles; and triazoles.

In addition to SARS-CoV-2, drugs and drug candidates for treating other life-threatening diseases often contain the N-containing heterocycles of different ring sizes, bearing different heteroatoms like oxygen and sulfur. New insights into the synthesis and synthetic methodologies of the heterocyclic motif would help to accelerate the drug development process. In the past decade, 4732 published reviews on heterocycles and heterocyclic chemistry have emerged from various academic disciplines, including chemistry, pharmacy, and materials. In particular, new robust synthetic methodologies relying on the use of practical and useful intermediates (e.g., radicals, cations, anions, carbenes, nitrenes, and benzynes) have been devised and successfully applied to the synthesis of heterocycles and fused derivatives.

This Special Issue of Molecules will comprise original research articles and reviews in the area of heterocycle chemistry considering synthesis and synthetic intermediates affording easy access to heterocycles and fused heterocycles that help to accelerate the drug discovery.

Prof. Dr. Mitsuhiro Yoshimatsu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heterocycles
  • synthetic methodologies
  • functionalizations
  • drug discovery
  • N-containing heterocycles
  • radicals
  • cations
  • anions
  • carbenes
  • nitrenes
  • benzynes

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop